Haemophilia with Mechanical Valve — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Factor IX replacement + warfarin at standard INR
Patients with haemophilia and mechanical valves require anticoagulation despite their bleeding disorder. Factor IX replacement is given to maintain adequate trough levels (typically >15–20% for factor IX in this setting), and warfarin is commenced at standard INR target for the valve type. This requires close collaboration between haematology and cardiology. DOACs are contraindicated for mechanical valves. The factor replacement provides haemostatic coverage for the warfarin-induced anticoagulation. Regular factor level monitoring is essential.
Reference: National Blood Authority – 2024 – Haemophilia Management; eTG – 2025 – Haematology